Indiana Animal Disease Diagnostic Laboratory Adopts PathFlow® for Digital Pathology Advancement Indiana Animal Disease Diagnostic Laboratory partners with Gestalt Diagnostics to adopt PathFlow® for enhancing digital pathology capabilities.

Indiana Animal Disease Diagnostic Laboratory Adopts PathFlow® for Digital Pathology Advancement #United_States #West_Lafayette #Gestalt_Diagnostics #PathFlow #ADDL

Gestalt Launches PathFlow Version 6 to Revolutionize Digital Pathology Experience Gestalt has unveiled PathFlow Version 6, enhancing digital pathology with improved workflows and features, ensuring pathologists can diagnose effectively.

Gestalt Launches PathFlow Version 6 to Revolutionize Digital Pathology Experience #None #Digital_Pathology #Gestalt_Diagnostics #PathFlow

Gestalt's PathFlow Showcases Advanced Interoperability at 2025 DICOM Connectathon At the Spring 2025 DICOM WG-26 Connectathon, Gestalt displayed its PathFlow platform, proving its readiness for integration in multi-vendor environments.

Gestalt's PathFlow Showcases Advanced Interoperability at 2025 DICOM Connectathon #USA #Spokane #Gestalt_Diagnostics #PathFlow #DICOM_Connectathon

Dr. Renuka Kulkarni Appointed as Chief Medical Officer at Gestalt Gestalt has announced the appointment of Dr. Renuka Kulkarni as Chief Medical Officer, enhancing their focus on AI-powered digital pathology solutions.

Dr. Renuka Kulkarni Appointed as Chief Medical Officer at Gestalt #USA #Digital_Pathology #Spokane #Gestalt_Diagnostics #Renuka_Kulkarni

Gestalt Diagnostics Secures $7.5 Million in Series A Funding to Enhance AI-Driven Pathology Solutions Gestalt Diagnostics has successfully closed a $7.5 million Series A funding round to enhance their AI-powered pathology platform, PathFlow, improving diagnostic capabilities.

Gestalt Diagnostics Secures $7.5 Million in Series A Funding to Enhance AI-Driven Pathology Solutions #USA #Spokane #AI_Pathology #Gestalt_Diagnostics #PathFlow